Malignant effusion seriously affects the quality of life of patients. Antineoplastic perfusion therapy can increase concentrations of the drug for longer periods and remove the small lesions in the chest and abdominal cavity. At present

the clinical drugs used for antineoplastic perfusion therapy are mainly chemotherapeutic agents such as platinum drugs

taxane and 5-fluorouracil

blood vessel formation inhibitor

bioimmunomodulators and antineoplastic traditional Chinese medicine injection. From the perspective of pharmacists

this article evaluates the characteristics

doses and safety of commonly used antineoplastic perfusion therapy drugs

and provides reference for clinical drug selection.